Dr. Reddy's Laboratories Limited (RDY)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Global Generics	299.03B	289.55B	245.45B	213.77B	179.17B
Global Generics Growth	3.27%	17.97%	14.82%	19.31%	21.47%
Pharmaceutical Services and Active Ingredients (PSAI)	42.04B	43.24B	40.58B	36.52B	37.00B
Pharmaceutical Services and Active Ingredients (PSAI) Growth	-2.76%	6.54%	11.12%	-1.29%	-4.87%
Others	2.13B	2.14B	3.91B	3.04B	4.48B
Others Growth	-0.47%	-45.35%	28.53%	-32.11%	34.32%
Inter-Segment Revenues	-7.27B	-9.39B	-10.78B	-7.45B	-6.26B
Total	335.93B	325.54B	279.16B	245.88B	214.39B
Total Growth	3.19%	16.61%	13.54%	14.69%	13.00%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
United States	117.89B	149.35B	135.57B	106.68B	80.56B
United States Growth	-21.06%	10.17%	27.07%	32.42%	5.04%
India	64.54B	55.83B	48.47B	50.50B	43.99B
India Growth	15.60%	15.18%	-4.01%	14.81%	21.33%
Russia	34.79B	25.96B	22.30B	21.23B	20.88B
Russia Growth	34.01%	16.40%	5.05%	1.67%	32.01%
Others	118.72B	94.40B	72.83B	67.47B	68.96B
Others Growth	25.77%	29.62%	7.94%	-2.16%	13.14%
Total	335.93B	325.54B	279.16B	245.88B	214.39B
Total Growth	3.19%	16.61%	13.54%	14.69%	13.00%

Data Source: S&P Global Market Intelligence Last updated: May 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error